As of May 29, 2025, MPX International Corp (MPXI.CN) reports a Gross Margin of 65.40%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Historical Trend of MPX International Corp's Gross Margin
Over recent years, MPX International Corp's Gross Margin has shown a moderate pattern. The table below summarizes the historical values:
| Date | Gross Margin |
|---|---|
| 2021-09-30 | 65.40% |
| 2020-09-30 | 82.04% |
| 2019-09-30 | 81.68% |
| 2018-09-30 | 46.49% |
This slight upward trend highlights how MPX International Corp manages its operational efficiency and pricing power over time.
Comparing MPX International Corp's Gross Margin to Peers
To better understand MPX International Corp's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| MPX International Corp (MPXI.CN) | 65.40% |
| Exmceuticals Inc (EXM.CN) | 7775.20% |
| American Green Inc (ERBB) | 7775.20% |
| Titan Pharmaceuticals Inc (TTNP) | 100.00% |
| Intellipharmaceutics International Inc (IPCI.TO) | 100.00% |
| Biostem Technologies Inc (BSEM) | 95.45% |
Compared to its competitors, MPX International Corp's Gross Margin is among the highest compared to peers, indicating superior product pricing power or cost efficiency in production.